or Try an Advanced Search...

    Macular Edema Stocks List

    Symbol Grade Name % Change
    OPT B Opthea Limited -0.54
    OCS B Oculis Holding AG 0.91
    CLSD C Clearside Biomedical, Inc. 0.00
    ALIM C Alimera Sciences, Inc. 0.00
    RZLT C Rezolute, Inc. 2.61
    EPRX C Eupraxia Pharmaceuticals Inc. 0.00
    REGN D Regeneron Pharmaceuticals, Inc. -0.63
    KALV F KalVista Pharmaceuticals, Inc. 3.95
    OCUP F Ocuphire Pharma, Inc. 5.56
    EYPT F EyePoint Pharmaceuticals, Inc. 2.63
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
    Related Stock Lists: Diabetic Macular Edema Medicine Biopharmaceutical Diabetic Retinopathy Eye Diabetes Ophthalmology Organ Systems Blindness Macular Degeneration Biotechnology Disease Inflammation Ophthalmic Retina Angiogenesis Diketones Dry Eye Disease Eye Diseases Fluocinolone

    Related ETFs - A few ETFs which own one or more of the above listed Macular Edema stocks.

    Symbol Grade Name Weight
    IWC C iShares Microcap ETF 0.05
    AVSC C Avantis U.S. Small Cap Equity ETF 0.01
    VXF B Vanguard Extended Market ETF 0.0
    DFAS C Dimensional U.S. Small Cap ETF 0.0
    DFAT C Dimensional U.S. Targeted Value ETF 0.0
    View all Macular Edema ETFs...
    Compare ETFs
    Compare IWC to AVSC Compare IWC to DFAT Compare VXF to DFAT

        Macular Edema Stocks Recent News

        Date Stock Title
        Oct 2 KALV High Growth Tech Stocks To Watch In The United States
        Oct 2 OCS Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
        Sep 30 REGN Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
        Sep 30 OCUP Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
        Sep 30 OPT Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
        Sep 30 KALV KalVista Announces the Submission of Additional Marketing Authorization Applications for Sebetralstat for the Oral On-Demand Treatment of Hereditary Angioedema
        Sep 29 REGN Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
        Sep 29 REGN Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
        Sep 29 REGN Regeneron: Long-Term Defensive Investment
        Sep 28 REGN Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
        Sep 28 REGN Wall Street Breakfast: What Moved Markets
        Sep 28 REGN Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): ‘Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling’
        Sep 27 REGN Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
        Sep 27 REGN Regeneron Shares Head for Worst Month Since 2019 on Legal Ruling
        Sep 27 REGN FDA greenlights Regeneron’s Dupixent for the treatment of COPD
        Sep 27 REGN Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
        Sep 27 REGN Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
        Sep 27 REGN Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
        Sep 27 REGN Sanofi, Regeneron get additional Chinese approval for Dupixent
        Sep 27 REGN Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
        Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Treatment Clinical Medicine Diabetes Diabetes Mellitus Diabetic Macular Edema Diabetic Retinopathy Insulin Kallikrein Life Sciences Medicine Metabolic Disease Monoclonal Antibody Plasma Kallikrein Specialty Drugs
        Macular Edema

        Macular edema is a condition in which fluid accumulates in the macula, the part of the eye responsible for central vision. It can cause blurred vision, difficulty reading, and other vision problems. Macular edema can be caused by a variety of conditions, including diabetes, retinal vein occlusion, and uveitis. Treatment may include medications, laser therapy, or surgery.

        Browse All Tags